Siddharth Singh

65PUBLICATIONS
86CO-AUTHORS
Infant and child healthDisease surveillanceMedical biotechnology diagnostics (incl. biosensors)Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Oct 07, 2026
Evolving Treatment Patterns and Clinical Outcomes in Children with Newly Diagnosed Crohn's Disease and Ulcerative Colitis in the United States, 2007-2023.

|Apr 03, 2026
An Enhanced Treatment Algorithm Targeting Mucosal Healing Is Effective and Safe in Older Patients With Crohn's Disease: A Post Hoc Analysis of the REACT2 Trial.

Shane W Goodwin, Sudheer Kumar Vuyyuru, Rocio Sedano

|Jan 07, 2026
Real-World Implementation of Treat to Target in Patients With IBD in a Learning Health System: An IBD Qorus Collaborative Study.

Siddharth Singh, Brant J Oliver, Jason K Hou

|Oct 29, 2025
Research Communication: Risk of Tuberculosis With Advanced Therapies in 20,705 Patients With Inflammatory Bowel Diseases in Low Incidence Regions-A U.S. Claims-Based Study.

Dhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel

|Oct 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases.

Dhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh

|Mar 31, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.

Siddharth Singh, Jasmine D Nguyen, David I Fudman

Pageof 11

Frequent Collaborators

17 joint publications

Vipul Jairath

15 joint publications

William Sandborn

15 joint publications

Christopher Ma

14 joint publications

Parambir S Dulai